CSGS CSG Systems International | $53.21 -0.3% | 12/22/2023 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 12/22/2023 |
RKLB Rocket Lab USA | $5.53 -4.5% | 12/22/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 12/22/2023 |
ZVRA Zevra Therapeutics | $6.55 +14.9% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 12/18/2023 |
ZLAB Zai Lab | $27.33 +0.1% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 12/18/2023 |
ONC Oncolytics Biotech | C$1.79 -0.6% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Oncolytics Biotech (TSE:ONC) on 12/18/2023 |
SPRO Spero Therapeutics | $1.47 +0.7% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 12/18/2023 |
|
SCYX SCYNEXIS | $2.23 +2.8% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 12/18/2023 |
PFE Pfizer | $28.79
| 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 12/18/2023 |
PDSB PDS Biotechnology | $4.97 -2.5% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 12/18/2023 |
PCVX Vaxcyte | $62.80 -0.8% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 12/18/2023 |
NVO Novo Nordisk A/S | $103.45 0.0% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 12/18/2023 |
MRK Merck & Co., Inc. | $109.02 +0.2% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 12/18/2023 |
MESO Mesoblast | $1.10 +1.9% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 12/18/2023 |
LYRA Lyra Therapeutics | $5.24 +5.4% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Lyra Therapeutics (NASDAQ:LYRA) on 12/18/2023 |
LLY Eli Lilly and Company | $582.92 +0.4% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 12/18/2023 |
JNJ Johnson & Johnson | $156.74 +0.1% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 12/18/2023 |
IMAB I-Mab | $1.90 +3.8% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of I-Mab (NASDAQ:IMAB) on 12/18/2023 |
HCM HUTCHMED | $18.11 +2.7% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of HUTCHMED (NASDAQ:HCM) on 12/18/2023 |
ATOS Atossa Therapeutics | $0.88 -10.2% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 12/18/2023 |
ARDX Ardelyx | $6.20 -3.4% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 12/18/2023 |
ANL Adlai Nortye | $8.99 +4.9% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Adlai Nortye (NASDAQ:ANL) on 12/18/2023 |
AMRN Amarin | $0.87 -3.3% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Amarin (NASDAQ:AMRN) on 12/18/2023 |
AMAM Ambrx Biopharma | $14.24 -1.8% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Ambrx Biopharma (NYSE:AMAM) on 12/18/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Neutral | | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/18/2023 |
QURE uniQure | $6.77 -0.9% | 12/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 12/20/2023 |
ASND Ascendis Pharma A/S | $125.95 -1.1% | 12/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $152.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 12/20/2023 |
AXSM Axsome Therapeutics | $79.59 0.0% | 12/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/20/2023 |
BIIB Biogen | $258.77 -0.7% | 12/20/2023 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $311.00 | Low | View details for Cantor Fitzgerald rating of Biogen (NASDAQ:BIIB) on 12/20/2023 |
IRON Disc Medicine | $57.76 +1.4% | 12/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 12/20/2023 |
CCJ Cameco | $43.10 +0.5% | 12/19/2023 | Downgraded by | Cantor Fitzgerald | - | Buy -> Neutral | | Low | View details for Cantor Fitzgerald rating of Cameco (NYSE:CCJ) on 12/19/2023 |
LBPH Longboard Pharmaceuticals | $6.03 -2.7% | 12/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 12/19/2023 |
CIFR Cipher Mining | $4.13 -14.1% | 12/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 12/19/2023 |
CRNX Crinetics Pharmaceuticals | $35.58 -0.5% | 12/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/19/2023 |
ADMA ADMA Biologics | $4.52
| 12/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 12/19/2023 |
TSHA Taysha Gene Therapies | $1.77 -0.6% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 12/18/2023 |
PTCT PTC Therapeutics | $27.56 -3.6% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 12/18/2023 |
PRTA Prothena | $36.34 -5.5% | 12/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $129.00 | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 12/18/2023 |
CNC Centene | $74.21 +0.4% | 12/15/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $82.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 12/15/2023 |
ITCI Intra-Cellular Therapies | $71.62 -0.5% | 12/14/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $101.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 12/14/2023 |
ACAD ACADIA Pharmaceuticals | $31.31 -0.3% | 12/14/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 12/14/2023 |
|
ALNY Alnylam Pharmaceuticals | $191.41 -2.2% | 12/14/2023 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/14/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 12/14/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $380.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/14/2023 |
LFMD LifeMD | $8.29 -0.5% | 12/14/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 12/14/2023 |
ML MoneyLion | $62.69 -4.1% | 12/13/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of MoneyLion (NYSE:ML) on 12/13/2023 |
KRYS Krystal Biotech | $124.06 -2.9% | 12/13/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 12/13/2023 |
MVST Microvast | $1.40 -4.1% | 12/13/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Microvast (NASDAQ:MVST) on 12/13/2023 |
FUBO fuboTV | $3.18 -3.9% | 12/12/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 12/12/2023 |
CXM Sprinklr | $12.04 -1.5% | 12/7/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 -> $16.00 | Low | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 12/7/2023 |
CERE Cerevel Therapeutics | $42.40 -0.1% | 12/7/2023 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | $38.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Cerevel Therapeutics (NASDAQ:CERE) on 12/7/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 12/5/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $380.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/5/2023 |
GTLB GitLab | $62.96 -2.6% | 12/5/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $55.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 12/5/2023 |
LUNR Intuitive Machines | $2.56 +4.9% | 12/5/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 12/5/2023 |
RIOT Riot Platforms | $15.47 -12.1% | 12/4/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 12/4/2023 |
IREN Iris Energy | $7.15 -16.3% | 12/4/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 12/4/2023 |
CIFR Cipher Mining | $4.13 -14.1% | 12/4/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 12/4/2023 |
CRNX Crinetics Pharmaceuticals | $35.58 -0.5% | 12/4/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/4/2023 |
RCM R1 RCM | $10.57 -1.5% | 12/4/2023 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 12/4/2023 |
BIVI BioVie | $1.26 +3.3% | 11/30/2023 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of BioVie (NASDAQ:BIVI) on 11/30/2023 |
CLSK CleanSpark | $11.03 -15.9% | 12/1/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 12/1/2023 |
NVO Novo Nordisk A/S | $103.45 0.0% | 12/1/2023 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 12/1/2023 |
REE REE Automotive | $5.14 -1.3% | 12/1/2023 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Underweight | | Low | View details for Cantor Fitzgerald rating of REE Automotive (NASDAQ:REE) on 12/1/2023 |
MRK Merck & Co., Inc. | $109.02 +0.2% | 11/29/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 11/29/2023 |
CRWD CrowdStrike | $255.32 -0.3% | 11/29/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $240.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/29/2023 |
BITF Bitfarms | $2.91 -12.3% | 11/29/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 11/29/2023 |
NNOX Nano-X Imaging | $6.37 -3.9% | 11/29/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 11/29/2023 |
MVST Microvast | $1.40 -4.1% | 11/29/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Microvast (NASDAQ:MVST) on 11/29/2023 |
ZS Zscaler | $221.56 -1.3% | 11/28/2023 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $185.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/28/2023 |
RIOT Riot Platforms | $15.47 -12.1% | 11/27/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 11/27/2023 |
MIRM Mirum Pharmaceuticals | $29.52 -1.5% | 11/27/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 11/27/2023 |
SLS SELLAS Life Sciences Group | $1.06 -2.8% | 11/22/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 11/22/2023 |
GTLB GitLab | $62.96 -2.6% | 11/22/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $55.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 11/22/2023 |
CNC Centene | $74.21 +0.4% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 11/21/2023 |
CVS CVS Health | $78.96 0.0% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 11/21/2023 |
ELV Elevance Health | $471.56 +0.6% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $547.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 11/21/2023 |
HUM Humana | $457.81 +0.5% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $597.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 11/21/2023 |
MOH Molina Healthcare | $361.31 +1.4% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $374.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 11/21/2023 |
UNH UnitedHealth Group | $526.47 +0.3% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 11/21/2023 |
CRWD CrowdStrike | $255.32 -0.3% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/21/2023 |
FTNT Fortinet | $58.53 -1.5% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/21/2023 |
ZS Zscaler | $221.56 -1.3% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/21/2023 |
SYM Symbotic | $51.33 -3.5% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 11/21/2023 |
RCEL AVITA Medical | $13.72 -3.9% | 11/21/2023 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 11/21/2023 |
MYNZ Mainz Biomed | $1.16 -1.7% | 11/21/2023 | Downgraded by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Mainz Biomed (NASDAQ:MYNZ) on 11/21/2023 |
PFE Pfizer | $28.79
| 11/20/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 11/20/2023 |
BITF Bitfarms | $2.91 -12.3% | 11/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 11/20/2023 |
CIFR Cipher Mining | $4.13 -14.1% | 11/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 11/20/2023 |
CLSK CleanSpark | $11.03 -15.9% | 11/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 11/20/2023 |
PTCT PTC Therapeutics | $27.56 -3.6% | 11/20/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 11/20/2023 |
GRCL Gracell Biotechnologies | $10.04 +1.1% | 11/15/2023 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | Low | View details for Cantor Fitzgerald rating of Gracell Biotechnologies (NASDAQ:GRCL) on 11/15/2023 |
JNJ Johnson & Johnson | $156.74 +0.1% | 11/17/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 11/17/2023 |
|
PAGS PagSeguro Digital | $12.47 -2.0% | 11/17/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 11/17/2023 |
GDYN Grid Dynamics | $13.33 -2.6% | 11/17/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 11/17/2023 |
PANW Palo Alto Networks | $294.88 -0.2% | 11/16/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $280.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/16/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 11/16/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $380.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/16/2023 |
VNRX VolitionRx | $0.72 +9.1% | 11/16/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.10 -> $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 11/16/2023 |
STNE StoneCo | $18.03 -1.4% | 11/16/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of StoneCo (NASDAQ:STNE) on 11/16/2023 |
ASXC Asensus Surgical | $0.32 -5.9% | 11/16/2023 | Downgraded by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Neutral | | N/A | View details for Cantor Fitzgerald rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 11/16/2023 |
MIRM Mirum Pharmaceuticals | $29.52 -1.5% | 11/15/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 11/15/2023 |
LLY Eli Lilly and Company | $582.92 +0.4% | 11/15/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 11/15/2023 |
MRK Merck & Co., Inc. | $109.02 +0.2% | 11/15/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 11/15/2023 |
SMTI Sanara MedTech | $41.10 -1.2% | 11/15/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $59.00 -> $49.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 11/15/2023 |
TSHA Taysha Gene Therapies | $1.77 -0.6% | 11/15/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/15/2023 |
CABA Cabaletta Bio | $22.70 -2.7% | 11/15/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 11/15/2023 |
BMY Bristol-Myers Squibb | $51.31 +0.2% | 11/15/2023 | Downgraded by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Neutral | $68.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 11/15/2023 |
ELUT Elutia | $2.16 +1.9% | 11/14/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 11/14/2023 |
MVIS MicroVision | $2.66 -3.3% | 11/14/2023 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 11/14/2023 |
JOBY Joby Aviation | $6.65 -3.6% | 11/14/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 11/14/2023 |
WULF TeraWulf | $2.40 -20.5% | 11/14/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 11/14/2023 |
LFMD LifeMD | $8.29 -0.5% | 11/14/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 11/14/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 11/14/2023 | Downgraded by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/14/2023 |
TMC TMC the metals | $1.10 -6.0% | 11/13/2023 | Initiated by | Cantor Fitzgerald | - | Buy | $4.20 | Low | View details for Cantor Fitzgerald rating of TMC the metals (NASDAQ:TMC) on 11/13/2023 |
SOUN SoundHound AI | $2.12 -4.9% | 11/10/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.20 -> $3.60 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 11/10/2023 |
EVLV Evolv Technologies | $4.72 -5.0% | 11/10/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 -> $8.00 | Low | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 11/10/2023 |
OMER Omeros | $3.27 -7.1% | 11/10/2023 | Downgraded by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 11/10/2023 |
NPCE NeuroPace | $10.31 +3.1% | 11/10/2023 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 11/10/2023 |
TWOU 2U | $1.23 -6.1% | 11/10/2023 | Downgraded by | Cantor Fitzgerald | - | Overweight -> Neutral | $5.30 -> $1.50 | Low | View details for Cantor Fitzgerald rating of 2U (NASDAQ:TWOU) on 11/10/2023 |
MLTX MoonLake Immunotherapeutics | $60.39 -1.8% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $78.00 | Low | View details for Cantor Fitzgerald rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/8/2023 |
BCYC Bicycle Therapeutics | $18.08 -3.3% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Bicycle Therapeutics (NASDAQ:BCYC) on 11/8/2023 |
RIVN Rivian Automotive | $23.46 -0.3% | 11/8/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 -> $27.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 11/8/2023 |
CERS Cerus | $2.16 -4.4% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $9.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 11/8/2023 |
SHLS Shoals Technologies Group | $15.54 -1.8% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/8/2023 |
PRCH Porch Group | $3.08 -5.2% | 11/8/2023 | Target Lowered by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $6.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 11/8/2023 |
PWSC PowerSchool | $23.56 -1.1% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of PowerSchool (NYSE:PWSC) on 11/8/2023 |
SSTI SoundThinking | $25.54 +2.4% | 11/8/2023 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 11/8/2023 |
NRDY Nerdy | $3.43 -2.6% | 11/8/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Nerdy (NYSE:NRDY) on 11/8/2023 |
RCUS Arcus Biosciences | $19.10 -2.7% | 11/8/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $46.00 -> $36.00 | Low | View details for Cantor Fitzgerald rating of Arcus Biosciences (NYSE:RCUS) on 11/8/2023 |
ENVX Enovix | $12.52 -2.9% | 11/8/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 11/8/2023 |
BITF Bitfarms | $2.91 -12.3% | 11/8/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 11/8/2023 |
CBAY CymaBay Therapeutics | $23.62 -1.5% | 11/8/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of CymaBay Therapeutics (NASDAQ:CBAY) on 11/8/2023 |
CRBU Caribou Biosciences | $5.73 -2.6% | 11/8/2023 | Initiated by | Cantor Fitzgerald | Analyst R. Bienkowski | Neutral | | Low | View details for Cantor Fitzgerald rating of Caribou Biosciences (NASDAQ:CRBU) on 11/8/2023 |
LCID Lucid Group | $4.21 -1.2% | 11/8/2023 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $10.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 11/8/2023 |
SIBN SI-BONE | $20.99 -1.8% | 11/7/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 11/7/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 11/7/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $370.00 -> $380.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/7/2023 |
KRYS Krystal Biotech | $124.06 -2.9% | 11/7/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 11/7/2023 |
AXSM Axsome Therapeutics | $79.59 0.0% | 11/7/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 11/7/2023 |
CI The Cigna Group | $299.45 +0.0% | 11/3/2023 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $310.00 -> $334.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 11/3/2023 |
UDMY Udemy | $14.73 -1.9% | 11/3/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $15.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 11/3/2023 |
CLDX Celldex Therapeutics | $39.66 -0.9% | 11/3/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $54.00 -> $52.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 11/3/2023 |
ITCI Intra-Cellular Therapies | $71.62 -0.5% | 11/3/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $98.00 -> $101.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 11/3/2023 |
HUM Humana | $457.81 +0.5% | 11/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $597.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 11/2/2023 |
|
CSGS CSG Systems International | $53.21 -0.3% | 11/2/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $68.00 -> $63.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 11/2/2023 |
BMRN BioMarin Pharmaceutical | $96.42 -0.7% | 11/2/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/2/2023 |
FTNT Fortinet | $58.53 -1.5% | 11/3/2023 | Downgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Neutral | $75.00 -> $50.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/3/2023 |
IMCR Immunocore | $68.32 -0.4% | 11/2/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Immunocore (NASDAQ:IMCR) on 11/2/2023 |
IMTX Immatics | $10.53 -2.5% | 11/2/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Immatics (NASDAQ:IMTX) on 11/2/2023 |
SRPT Sarepta Therapeutics | $96.43 -1.4% | 10/31/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Neutral | $166.00 -> $40.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 10/31/2023 |
PACB Pacific Biosciences of California | $9.81 -5.3% | 10/31/2023 | Upgraded by | Cantor Fitzgerald | Analyst R. Osborn | Neutral -> Overweight | $14.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of Pacific Biosciences of California (NASDAQ:PACB) on 10/31/2023 |
RIVN Rivian Automotive | $23.46 -0.3% | 10/27/2023 | Upgraded by | Cantor Fitzgerald | - | Neutral -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 10/27/2023 |
NXT Nextracker | $46.85 -1.3% | 10/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $52.00 | Low | View details for Cantor Fitzgerald rating of Nextracker (NASDAQ:NXT) on 10/26/2023 |
RKLB Rocket Lab USA | $5.53 -4.5% | 10/26/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 10/26/2023 |
CCJ Cameco | $43.10 +0.5% | 10/25/2023 | Upgraded by | Cantor Fitzgerald | - | Hold -> Buy | | Low | View details for Cantor Fitzgerald rating of Cameco (NYSE:CCJ) on 10/25/2023 |
XENE Xenon Pharmaceuticals | $46.06 -0.5% | 10/24/2023 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/24/2023 |
NBIX Neurocrine Biosciences | $131.76 -0.3% | 10/24/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/24/2023 |
LBPH Longboard Pharmaceuticals | $6.03 -2.7% | 10/24/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight | $16.00 -> $35.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 10/24/2023 |
CRNX Crinetics Pharmaceuticals | $35.58 -0.5% | 10/24/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight | $52.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 10/24/2023 |
DNLI Denali Therapeutics | $21.46 -2.2% | 10/24/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight | $85.00 -> $35.00 | Low | View details for Cantor Fitzgerald rating of Denali Therapeutics (NASDAQ:DNLI) on 10/24/2023 |
RCKT Rocket Pharmaceuticals | $29.97 -3.0% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/24/2023 |
MIRM Mirum Pharmaceuticals | $29.52 -1.5% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 10/24/2023 |
KRYS Krystal Biotech | $124.06 -2.9% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 10/24/2023 |
CABA Cabaletta Bio | $22.70 -2.7% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $40.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 10/24/2023 |
BBIO BridgeBio Pharma | $40.37 -3.4% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 10/24/2023 |
ANL Adlai Nortye | $8.99 +4.9% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Adlai Nortye (NASDAQ:ANL) on 10/24/2023 |
FDMT 4D Molecular Therapeutics | $20.26 -3.6% | 10/24/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $32.00 | Low | View details for Cantor Fitzgerald rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/24/2023 |
SMRT SmartRent | $3.19 -1.8% | 10/23/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of SmartRent (NYSE:SMRT) on 10/23/2023 |
LLY Eli Lilly and Company | $582.92 +0.4% | 10/23/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 10/23/2023 |
PRTA Prothena | $36.34 -5.5% | 10/23/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $129.00 | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 10/23/2023 |
AMAM Ambrx Biopharma | $14.24 -1.8% | 10/23/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of Ambrx Biopharma (NYSE:AMAM) on 10/23/2023 |
MRK Merck & Co., Inc. | $109.02 +0.2% | 10/23/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 10/23/2023 |
BEAM Beam Therapeutics | $27.22 -7.5% | 10/20/2023 | Downgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 10/20/2023 |
ELV Elevance Health | $471.56 +0.6% | 10/19/2023 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $547.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/19/2023 |
RCEL AVITA Medical | $13.72 -3.9% | 10/19/2023 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 10/19/2023 |
JNJ Johnson & Johnson | $156.74 +0.1% | 10/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/18/2023 |
BEAM Beam Therapeutics | $27.22 -7.5% | 10/17/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $56.00 -> $32.00 | Low | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 10/17/2023 |
EDIT Editas Medicine | $10.13 -2.1% | 10/17/2023 | Downgraded by | Cantor Fitzgerald | - | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Editas Medicine (NASDAQ:EDIT) on 10/17/2023 |
CRSP CRISPR Therapeutics | $62.60 -2.6% | 10/17/2023 | Downgraded by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 10/17/2023 |
BLUE bluebird bio | $1.38 -2.1% | 10/17/2023 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Neutral | | Low | View details for Cantor Fitzgerald rating of bluebird bio (NASDAQ:BLUE) on 10/17/2023 |
ALNY Alnylam Pharmaceuticals | $191.41 -2.2% | 10/16/2023 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $190.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/16/2023 |
REGN Regeneron Pharmaceuticals | $878.29 -0.4% | 10/16/2023 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $800.00 -> $850.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 10/16/2023 |
VRTX Vertex Pharmaceuticals | $406.89 -0.6% | 10/16/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $370.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/16/2023 |
BMRN BioMarin Pharmaceutical | $96.42 -0.7% | 10/16/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/16/2023 |
IMVT Immunovant | $42.13 -0.5% | 10/16/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 10/16/2023 |
JSPR Jasper Therapeutics | $0.79 +9.7% | 10/12/2023 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Jasper Therapeutics (NASDAQ:JSPR) on 10/12/2023 |
CLDX Celldex Therapeutics | $39.66 -0.9% | 10/12/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $54.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 10/12/2023 |
GENI Genius Sports | $6.18 -3.0% | 10/12/2023 | Initiated by | Cantor Fitzgerald | - | Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Genius Sports (NYSE:GENI) on 10/12/2023 |
HYLN Hyliion | $0.81 -6.9% | 10/12/2023 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Underweight | $2.00 -> $1.00 | Low | View details for Cantor Fitzgerald rating of Hyliion (NYSE:HYLN) on 10/12/2023 |
AKRO Akero Therapeutics | $23.35 -2.8% | 10/11/2023 | Target Lowered by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $69.00 -> $39.00 | Low | View details for Cantor Fitzgerald rating of Akero Therapeutics (NASDAQ:AKRO) on 10/11/2023 |
IREN Iris Energy | $7.15 -16.3% | 10/10/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/10/2023 |
PSTX Poseida Therapeutics | $3.36 -3.4% | 10/10/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Poseida Therapeutics (NASDAQ:PSTX) on 10/10/2023 |
RIOT Riot Platforms | $15.47 -12.1% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 10/9/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $38.00 | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 10/9/2023 |
|
IMVT Immunovant | $42.13 -0.5% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 10/9/2023 |
JNJ Johnson & Johnson | $156.74 +0.1% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/9/2023 |
ZLAB Zai Lab | $27.33 +0.1% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $70.00 | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 10/9/2023 |
BMY Bristol-Myers Squibb | $51.31 +0.2% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 10/9/2023 |
LLY Eli Lilly and Company | $582.92 +0.4% | 10/9/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 10/9/2023 |
CYTK Cytokinetics | $83.49 +0.3% | 10/9/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $59.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 10/9/2023 |
ORTX Orchard Therapeutics | $16.45 +0.2% | 10/6/2023 | Downgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Orchard Therapeutics (NASDAQ:ORTX) on 10/6/2023 |
KE Kimball Electronics | $26.95 -1.3% | 10/4/2023 | Reiterated by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $36.00 | Low | View details for Cantor Fitzgerald rating of Kimball Electronics (NASDAQ:KE) on 10/4/2023 |
AKRO Akero Therapeutics | $23.35 -2.8% | 10/4/2023 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $69.00 | Low | View details for Cantor Fitzgerald rating of Akero Therapeutics (NASDAQ:AKRO) on 10/4/2023 |
ALXO ALX Oncology | $14.89 -2.6% | 10/4/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $23.00 | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 10/4/2023 |
ZFOX ZeroFox | $0.87 -2.2% | 10/4/2023 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of ZeroFox (NASDAQ:ZFOX) on 10/4/2023 |
NNOX Nano-X Imaging | $6.37 -3.9% | 10/3/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 10/3/2023 |
LFMD LifeMD | $8.29 -0.5% | 10/2/2023 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $8.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 10/2/2023 |
DCGO DocGo | $5.59 -0.4% | 10/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 10/2/2023 |
CPSI Computer Programs and Systems | $11.20 -1.5% | 10/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Computer Programs and Systems (NASDAQ:CPSI) on 10/2/2023 |
JNJ Johnson & Johnson | $156.74 +0.1% | 10/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/2/2023 |
LLY Eli Lilly and Company | $582.92 +0.4% | 10/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $630.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 10/2/2023 |
MRK Merck & Co., Inc. | $109.02 +0.2% | 10/2/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 10/2/2023 |
PFE Pfizer | $28.79
| 10/2/2023 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/2/2023 |
SPT Sprout Social | $61.44 -2.6% | 9/28/2023 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $44.00 -> $48.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 9/28/2023 |
CLDX Celldex Therapeutics | $39.66 -0.9% | 9/27/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $54.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/27/2023 |
SIBN SI-BONE | $20.99 -1.8% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 9/26/2023 |
SMTI Sanara MedTech | $41.10 -1.2% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $59.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 9/26/2023 |
XGN Exagen | $1.99 -2.0% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 9/26/2023 |
AWH Aspira Women's Health | $4.08 -1.0% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 9/26/2023 |
AXGN AxoGen | $6.83 -0.7% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of AxoGen (NASDAQ:AXGN) on 9/26/2023 |
ELUT Elutia | $2.16 +1.9% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 9/26/2023 |
LUCD Lucid Diagnostics | $1.41 -2.1% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 9/26/2023 |
MYNZ Mainz Biomed | $1.16 -1.7% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of Mainz Biomed (NASDAQ:MYNZ) on 9/26/2023 |
NNOX Nano-X Imaging | $6.37 -3.9% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 9/26/2023 |
PACB Pacific Biosciences of California | $9.81 -5.3% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $14.00 | Low | View details for Cantor Fitzgerald rating of Pacific Biosciences of California (NASDAQ:PACB) on 9/26/2023 |
PRE Prenetics Global | $5.91 -0.5% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 9/26/2023 |
RCEL AVITA Medical | $13.72 -3.9% | 9/26/2023 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 9/26/2023 |
SLNO Soleno Therapeutics | $40.25 +2.0% | 9/26/2023 | Target Raised by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $19.00 -> $35.00 | Low | View details for Cantor Fitzgerald rating of Soleno Therapeutics (NASDAQ:SLNO) on 9/26/2023 |
BITF Bitfarms | $2.91 -12.3% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 9/25/2023 |
CIFR Cipher Mining | $4.13 -14.1% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 9/25/2023 |
CLSK CleanSpark | $11.03 -15.9% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 9/25/2023 |
RIOT Riot Platforms | $15.47 -12.1% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 9/25/2023 |
WULF TeraWulf | $2.40 -20.5% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 9/25/2023 |
RARE Ultragenyx Pharmaceutical | $47.82 -0.9% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $114.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/25/2023 |
IREN Iris Energy | $7.15 -16.3% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 9/25/2023 |
AFMD Affimed | $0.63 +16.8% | 9/25/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 9/25/2023 |
CRWD CrowdStrike | $255.32 -0.3% | 9/22/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 9/22/2023 |
PAYO Payoneer Global | $5.21 -1.1% | 9/22/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Payoneer Global (NASDAQ:PAYO) on 9/22/2023 |
SLDB Solid Biosciences | $6.14 -8.8% | 9/22/2023 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | Low | View details for Cantor Fitzgerald rating of Solid Biosciences (NASDAQ:SLDB) on 9/22/2023 |
ALEC Alector | $7.98 -0.3% | 9/22/2023 | Initiated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 9/22/2023 |
REGN Regeneron Pharmaceuticals | $878.29 -0.4% | 9/21/2023 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $800.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 9/21/2023 |
MESO Mesoblast | $1.10 +1.9% | 9/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $17.00 | Low | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 9/21/2023 |
HUMA Humacyte | $2.84 -4.4% | 9/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 9/21/2023 |
MRNS Marinus Pharmaceuticals | $10.87 -1.1% | 9/21/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/21/2023 |
SEEL Seelos Therapeutics | $1.39 -4.1% | 9/20/2023 | Downgraded by | Cantor Fitzgerald | Analyst C. Duncan | Overweight -> Neutral | | Low | View details for Cantor Fitzgerald rating of Seelos Therapeutics (NASDAQ:SEEL) on 9/20/2023 |
MTA Metalla Royalty & Streaming | $3.08 +0.7% | 9/19/2023 | Downgraded by | Cantor Fitzgerald | - | Buy -> Sell | | N/A | View details for Cantor Fitzgerald rating of Metalla Royalty & Streaming (NYSEMKT:MTA) on 9/19/2023 |
ACRS Aclaris Therapeutics | $1.05 -1.9% | 9/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $38.00 | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 9/19/2023 |
RZLT Rezolute | $0.99
| 9/19/2023 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Rezolute (NASDAQ:RZLT) on 9/19/2023 |
INSM Insmed | $30.99 -2.4% | 9/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $46.00 | Low | View details for Cantor Fitzgerald rating of Insmed (NASDAQ:INSM) on 9/19/2023 |
ELUT Elutia | $2.16 +1.9% | 9/19/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 9/19/2023 |
PRE Prenetics Global | $5.91 -0.5% | 9/19/2023 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $60.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 9/19/2023 |
AKRO Akero Therapeutics | $23.35 -2.8% | 9/19/2023 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $69.00 | Low | View details for Cantor Fitzgerald rating of Akero Therapeutics (NASDAQ:AKRO) on 9/19/2023 |
AVPT AvePoint | $8.21 -1.7% | 9/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 9/18/2023 |
COUR Coursera | $19.37 -1.1% | 9/18/2023 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $17.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 9/18/2023 |